Aligos Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D

To become a world leader in the development of targeted antiviral therapies for chronic hepatitis B (CHB) and COVID-19 and to leverage our expertise in liver diseases to create optimized therapeutics for MASH.
Address
South San FranciscoCA
United States